The Hong Kong Association for the Study of Liver Diseases
香港肝病學會
About Us
President's Message
Dear Friends and Colleagues,
A warm welcome to the Hong Kong Association for the Study of Liver Diseases (HKASLD). Since 1987, we have served as the cornerstone for hepatology professionals across Hong Kong with a mission to advance our specialty through education, research, and collaboration.
Together with our Council, we have the distinct privilege of serving you in this era of unprecedented progress in hepatology. The HKASLD represents a diverse community of clinicians, researchers, nurses, and allied health professionals united by a shared commitment to improving liver health. Following the historic achievement of curing chronic hepatitis C, we are now witnessing the accelerated development of innovative therapies for chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease, with various studies being led by researchers based in Hong Kong. Locally, these scientific strides have been complemented by public health initiatives as well. The upcoming introduction of the Hepatitis B Co-care Scheme by the Primary Healthcare Commission hopes to identify people with chronic hepatitis B in the community and to provide clear linkage-to-care pathways with a view to reducing the risk of developing liver related complications, such as cirrhosis and liver cancer, in the future.
To keep pace with these rapid developments, the HKASLD provides its members with a dynamic platform for education and exchange. Through our regular scientific meetings, multidisciplinary symposia, and our flagship Annual Scientific Meeting, we hope to gather world-renowned experts in Hong Kong to share their cutting-edge research, pioneering therapies and best practices to ensure that we are at the forefront of science.
If you are a healthcare professional or scientist with an interest in hepatology, we warmly encourage you to become a part of our growing community. We look forward to welcoming you personally at one of our upcoming events, and to working together in shaping the future of liver care in Hong Kong.
With best regards,
Dr Rashid Lui
President
The Hong Kong Association for the Study of Liver Diseases
Objectives
-
To promote the advancement of the study of the liver.
-
To provide a platform for healthcare professionals and researchers to share and disseminate the latest advances in hepatology
-
Raise the awareness of liver health among the public, patient groups, healthcare professionals, policymakers, and other stakeholders.
-
Patient advocacy and to help shape related healthcare policies
-
To form global alliances and collaborate with international partners
Council Members
PRESIDENT
Dr. Rashid Nok-Shun Lui
VICE-PRESIDENT
Prof. Loey Lung-Yi Mak
HONORARY SECRETARY
Dr. Michael Kwan-Lung Ko
HONORARY TREASURER
Prof. Terry Cheuk-Fung Yip
COUNCIL MEMBERS
Dr. Chun-Wing Chan
Prof. Henry Lik-Yuen Chan
Dr. Kam-Hon Chan
Dr. Kevin Chi-Wing Chow
Dr. James Yan-Yue Fung
Dr. Rex Wan-Hin Hui
Dr. Kam-Ngai Kung
Prof. Jimmy Che-To Lai
Dr. Thomas Sik-To Lai
Dr. Francis Tat-Wing Li
Dr. Michael Kin-Kong Li
Dr. Henry Hin-Wai Liu
Dr. Ching-Kong Loo
Prof. Walter Wai-Kay Seto
Prof. Man-Fung Yuen
EX-OFFICIO
Prof. Grace Lai-Hung Wong
PAST PRESIDENTS
Prof. Grace Lai-Hung Wong (2024-2025)
Dr. James Yan-Yue Fung (2021-2023)
Dr. Yee-Tak Hui (2019-2021)
Dr. Ching-Kong Loo (2017-2019)
Prof. Vincent Wai-Sun Wong (2015-2017)
Dr. Steven Woon-Choy Tsang (2013-2015)
Dr. Tai-Nin Chau (2011-2013)
Prof. Man-Fung Yuen (2009-2011)
Prof. Henry Lik-Yuen Chan (2005-2009)
Dr. Jak-Yiu Lai (2003-2005)
Dr. HY Lo (1999-2003)
Dr. Sik-To Lai (1995-1999)
Prof. Ching-Lung Lai (1989-1995)
Dr. EK Yeoh (19878-1989)